Viktor Zarev

Viktor Zarev

InvestorPlace Contributor

Expertise: Science, Technology, Defense, and Medicine Stock Review

Education: BS in Biology from Baylor University, MS in Computer Science from Pace University

Viktor Zarev is a Freelance Writer at InvestorPlace.com, where he aims to elucidate and simplify the world of high-tech stocks and cryptocurrencies. To accomplish this, Viktor specializes in distilling the most pertinent and critical details for investors to focus on.

He also writes in-depth research scripts for defense documentaries on YouTube as well as creative direction and copywriting for game studios. He is also a supply chain specialist in the defense industry.

Viktor holds a BS in Global Health Biology from Baylor University, where he graduated on the Medical Entomology Research Track, studying flaviviruses and developing vector control methods. He is currently earning an MS in Computer Science from Pace University, focusing on artificial intelligence and machine learning.

Recent Articles

3 Stocks to Buy Before the Nvidia Shareholder Meeting on June 26

By Viktor Zarev, InvestorPlace Contributor

These three stocks could see a boost as a result of increased investor activity after the upcoming Nvidia shareholder meeting.

3 Stocks to Snag While the Analysts Snooze

By Viktor Zarev, InvestorPlace Contributor

Sometimes the best stocks to buy are the ones least talked about in their sector with respectable growth and margins.

Wanna Be a Future Crypto Millionaire? Invest in POL, VET and BTC.

By Viktor Zarev, InvestorPlace Contributor

These could be the three best cryptos to buy to become a millionaire over the long run, if you can stomach the risk.

3 Biotech Stocks to Buy Now: June 2024

By Viktor Zarev, InvestorPlace Contributor

These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,

Hype-nosis: Snap Out of the Trance and See These 3 Stocks for What They Really Are

By Viktor Zarev, InvestorPlace Contributor

Sometimes its good to take profits on overvalued stocks before a price correction sinks your portfolio gains.

Load More